The researchers use a combination of electromechanical mapping with a NOGA system and positron emission tomography (PET) radiowater perfusion imaging to create 2-dimensional bull’s eye maps that guide the injection of the gene therapy into the heart muscle.  {read more here}

New study by researchers at the Intermountain Medical Center Heart Institute finds cardiac PET/CT imaging is effective in reducing risk of death, heart attack and stroke in patients.  {read more here}

Researchers at Princess Alexandra Hospital, Brisbane, Australia, have demonstrated that cardiac amyloidosis (abnormal deposits of proteins in the heart), which is notoriously difficult to diagnose, can be visualized noninvasively with positron emission tomography (PET) using the radiotracer fluorine-18 (F-18)-florbetaben. The study is published in the November issue of “The Journal of Nuclear Medicine.” {read more here}

Washington University researchers have developed a chemical compound they say can provide an early diagnosis for Alzheimer’s disease.  Patients with Alzheimer’s disease have normally incurred a significant degree of neurological damage by the time they are diagnosed. A research team says their new chemical compound, known as Fluselenamyl, is capable of detecting amyloid clumps better than current methods approved the by U.S. Food and Drug Administration. {read more here}